CN112125856A - Preparation method of 2-trifluoromethyl substituted quinazolinone derivative - Google Patents

Preparation method of 2-trifluoromethyl substituted quinazolinone derivative Download PDF

Info

Publication number
CN112125856A
CN112125856A CN202010936182.9A CN202010936182A CN112125856A CN 112125856 A CN112125856 A CN 112125856A CN 202010936182 A CN202010936182 A CN 202010936182A CN 112125856 A CN112125856 A CN 112125856A
Authority
CN
China
Prior art keywords
trifluoromethyl
substituted quinazolinone
quinazolinone derivative
substituted
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010936182.9A
Other languages
Chinese (zh)
Inventor
吴小锋
陈铮凯
杨合肥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN202010936182.9A priority Critical patent/CN112125856A/en
Publication of CN112125856A publication Critical patent/CN112125856A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses a preparation method of a 2-trifluoromethyl substituted quinazolinone derivative, which comprises the following steps: adding a palladium catalyst, a ligand, a carbon monoxide substitute, an additive, trifluoroethylimidoyl chloride and o-iodoaniline into an organic solvent, reacting for 16-30 hours at 90 ℃, and after the reaction is completed, carrying out post-treatment to obtain the 2-trifluoromethyl-substituted quinazolinone derivative. The preparation method is simple and convenient to operate, the initial reaction raw materials are cheap and easy to obtain, the method is compatible with various substituents, the substrate applicability is good, trifluoromethyl quinazolinone derivatives substituted by different groups can be synthesized through substrate design, the operation is convenient, and the practicability of the method is widened. The method adopts 1,3, 5-tricarboxylate phenol ester as a substitute of solid carbon monoxide, and avoids the use of toxic colorless gas carbon monoxide.

Description

Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a preparation method of a 2-trifluoromethyl-substituted quinazolinone derivative.
Background
Quinazolinone derivatives are important fused-ring nitrogen-containing six-membered heterocycles, widely found in various natural products and drug molecules, and have spectral biological and pharmaceutical activities such as anti-inflammatory, antiviral, antifungal, anticonvulsant, and anticancer properties (eur.j.med.chem.,2015,90, 124). Many commercially available drugs contain a quinazolinone molecular backbone, such as fluoroquinolone, mequinone, mecloquinone and benzoquinacridone. Due to the special properties of fluorine atoms, the introduction of trifluoromethyl groups into the molecule can significantly improve the physicochemical properties of the parent molecule, such as electronegativity, bioavailability, metabolic stability, lipophilicity, etc. (j.med.chem.2015,58, 8315-.
Figure BDA0002672002320000011
The literature reports today are very rich on the synthesis of substituted quinazolinone derivatives, but the synthesis of quinazolinone derivatives substituted with trifluoromethyl in the 2-position is very limited. Common synthetic methods include 1) cyclization reaction of anthranilamide with ethyl trifluoroacetate, trifluoroacetic anhydride and trifluoroacetic acid under different conditions; 2) cyclization of anthranilic acid ester with unstable trifluoroacetamide; 3) cyclization reaction of isatoic anhydride and trifluoroacetic anhydride; 4) T3P promoted the tandem reaction of anthranilic acid, trifluoroacetic acid and an amine. The above-described synthesis methods generally have several disadvantages, such as harsh reaction conditions, expensive reaction substrates or the need for pre-activation, low yield, and narrow substrate range.
Based on the method, cheap and easily-obtained trifluoroethylimidoyl chloride and o-iodoaniline are used as starting materials, 1,3, 5-tricarboxylate phenol ester is used as a solid carbon monoxide substitute, and a carbonylation tandem reaction catalyzed by transition metal palladium is used for efficiently synthesizing the 2-trifluoromethyl substituted quinazolinone.
Disclosure of Invention
The invention provides a preparation method of a 2-trifluoromethyl-substituted quinazolinone derivative, which is simple and convenient to operate, cheap and easily available in reaction starting raw materials, compatible with various substituent groups and good in substrate applicability, and 1,3, 5-tricarboxylate is adopted as a solid carbon monoxide substitute, so that the use of toxic colorless gas carbon monoxide is avoided.
A preparation method of 2-trifluoromethyl substituted quinazolinone derivatives comprises the following steps: adding a palladium catalyst, 1, 3-bis (diphenylphosphino) propane, potassium tert-butoxide, TFBen (1,3, 5-tricresol phenolate), trifluoroethylimidoyl chloride and o-iodoaniline into an organic solvent, reacting for 16-30 hours at 90 ℃, and after the reaction is completed, carrying out post-treatment to obtain the 2-trifluoromethyl-substituted quinazolinone derivative;
the structure of the o-iodoaniline is shown as the formula (II):
Figure BDA0002672002320000021
the structure of the trifluoroethylimidoyl chloride is shown as a formula (III):
Figure BDA0002672002320000022
the structure of the 2-trifluoromethyl substituted quinazolinone derivative is shown as the formula (I):
Figure BDA0002672002320000023
in formulae (I) to (III), R1Is H, C1~C5Alkyl, halogen or trifluoromethyl; r2Is a substituted or unsubstituted aryl group;
the substituent on the aryl is selected from C1~C5Alkyl, alkoxy, halogen or nitro.
The molar ratio of the palladium catalyst to the 1, 3-bis (diphenylphosphino) propane to the potassium tert-butoxide is 0.05:0.05: 2;
the substitution position on the aryl group may be ortho, para or meta.
The reaction formula is as follows:
Figure BDA0002672002320000031
during the reaction, intermolecular carbon-nitrogen bond coupling promoted by potassium tert-butoxide may be firstly carried out to obtain a trifluoroacetamidine derivative, then a palladium catalyst is inserted into a carbon-iodine bond to form a divalent palladium intermediate, TFBen is decomposed under heating conditions to release carbon monoxide, the carbon-iodine bond is inserted into a carbon-palladium bond to form an acylpalladium intermediate, palladium-nitrogen base formation is promoted under the action of alkali to obtain a seven-membered ring palladium intermediate, and then reduction elimination is carried out to obtain the final 2-trifluoromethyl-substituted quinazolinone derivative.
In the present invention, the optional post-processing procedure includes: filtering, mixing the sample with silica gel, and finally performing column chromatography purification to obtain the corresponding 2-trifluoromethyl-substituted quinazolinone derivative, wherein the column chromatography purification is a technical means commonly used in the field.
Preferably, R1Is H, methyl, F, Cl, Br or-CF3;R2Is phenyl, 4-methylphenyl, 2-methylphenyl, 4-chlorophenyl or 4-nitrophenyl, 1-naphthyl; at this time, the trifluoroethylimidoyl chloride and o-iodoaniline are easily obtained, and the yield of the reaction is high.
The prices of various types of trifluoroethylimidoyl chloride are low, the synthetic starting material aromatic amine widely exists in the nature, the synthetic process is simple, the dosage of the compound is excessive relative to the dosage of the o-iodoaniline, and preferably, the molar amount of the o-iodoaniline: trifluoroethylimidoyl chloride: palladium bis (triphenylphosphine) dichloride of 1:1 to 3:0.01 to 0.1; as a further preference, the molar amount of o-iodoaniline: trifluoroethylimidoyl chloride: palladium bis (triphenylphosphine) dichloride ═ 1:2: 0.05.
Preferably, the reaction time is 16 to 30 hours, and if the reaction time is too long, the reaction cost is increased, and on the contrary, the completion of the reaction is difficult to ensure.
In the present invention, the organic solvent capable of sufficiently dissolving the raw material can cause the reaction, but the difference in reaction efficiency is large, and the aprotic solvent is preferably an aprotic solvent which can effectively promote the reaction; preferably, the organic solvent is tetrahydrofuran, acetonitrile or dioxane; further preferably, the organic solvent is tetrahydrofuran, in which case various starting materials can be converted into products with high conversion.
The amount of the organic solvent can be used for better dissolving the raw materials, and the amount of the organic solvent used by 1mmol of o-iodoaniline is about 8-10 mL.
Preferably, the palladium catalyst is palladium bis (triphenylphosphine) dichloride, and the reaction efficiency is higher when the palladium bis (triphenylphosphine) dichloride is used as the catalyst in a plurality of palladium catalysts.
As a further preference, the 2-trifluoromethyl substituted quinazolinone derivative is one of the derivatives shown in formula (I-1) and formula (I-5):
Figure BDA0002672002320000041
in the preparation method, the various types of aromatic amine, phenol, formic acid, palladium bis (triphenylphosphine) dichloride and 1, 3-bis (diphenylphosphino) propane are generally commercially available products and can be conveniently obtained from the market, and the trifluoroethylimidoyl chloride can be quickly synthesized from corresponding aromatic amine, triphenylphosphine, carbon tetrachloride and trifluoroacetic acid.
Compared with the prior art, the invention has the advantages that: the preparation method is convenient to operate and simple in post-treatment; the initial raw materials for the reaction are cheap and easy to obtain, the designability of the substrate is strong, the application range of the substrate functional group is wide, the reaction efficiency is high, trifluoromethyl-substituted quinazolinone derivatives substituted by different positions and groups can be designed and synthesized according to needs, and the practicability is high.
Detailed Description
The invention is further described with reference to specific examples.
Adding palladium bis (triphenylphosphine) dichloride, 1, 3-bis (diphenylphosphino) propane, TFBen, potassium tert-butoxide, o-iodoaniline (II), trifluoroethylimidoyl chloride (III) and 2mL of an organic solvent into a 35mL Schlenk tube according to the raw material ratio of Table 1, uniformly mixing and stirring, reacting for 16-30 hours according to the reaction conditions of Table 2, filtering, stirring with silica gel, and purifying by column chromatography to obtain the corresponding 2-trifluoromethyl-substituted quinazolinone derivative (I), wherein the reaction process is shown as the following formula:
Figure BDA0002672002320000051
TABLE 1 raw material addition amounts of examples 1 to 15
Figure BDA0002672002320000052
TABLE 2
Figure BDA0002672002320000053
Figure BDA0002672002320000061
In tables 1 and 2, T is the reaction temperature, T is the reaction time, Ph is phenyl, napthyl is naphthyl, Me is methyl, T-Bu is T-butyl, CF3Is trifluoromethyl and THF is tetrahydrofuran.
Structure confirmation data of the derivatives prepared in examples 1 to 5:
nuclear magnetic resonance of 2-trifluoromethyl-substituted quinazolinone derivative (I-1) prepared in example 1: (1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0002672002320000062
1H NMR(400MHz,CDCl3)7.97-7.90(m,2H),7.98-7.90(m,1H),7.56-7.53(m,3H),7.32-7.28(m,2H).
13C NMR(101MHz,CDCl3)162.7(d,J(C-F)=252.7Hz),161.2,142.0,134.7,131.5(d,J(C-F)=8.5Hz),130.2,129.5,129.1,126.4,123.9(d,J(C-F)=24.1Hz),120.6,118.0(q,J(C-F)=277.4Hz),112.8(d,J(C-F)=24.1Hz).
19F NMR(377MHz,CDCl3)-63.9,-107.8.
M.p.124-125℃
HRMS(ESI):[M+H]+calcd.for C15H9F4N2O 309.0646,found 309.0651.
nuclear magnetic resonance of 2-trifluoromethyl-substituted quinazolinone derivative (I-2) prepared in example 2: (1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0002672002320000071
1H NMR(400MHz,CDCl3)8.26(d,J=8.5Hz,1H),7.90(s,1H),7.60(d,J=8.5Hz,1H),7.57-7.53(m,3H),7.30(d,J=3.7Hz,2H).
13C NMR(101MHz,CDCl3)161.3,146.3,143.6(q,J(C-F)=36.3Hz),141.8,134.6,130.3,129.5,129.1,129.0,128.4,120.7,117.8(q,J(C-F)=277.8Hz).
19F NMR(377MHz,CDCl3)-64.1.
M.p.125-126℃
HRMS(ESI):[M+H]+calcd.for C15H9ClF3N2O 325.0350,found 325.0354.
nuclear magnetic resonance of 2-trifluoromethyl-substituted quinazolinone derivative (I-3) prepared in example 3: (1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0002672002320000072
1H NMR(400MHz,CDCl3)8.33(d,J=7.7Hz,1H),7.93-7.85(m,2H),7.65(t,J=6.2Hz,1H),7.56-7.51(m,2H),7.22(d,J=8.0Hz,2H),1.38(s,9H).
13C NMR(101MHz,CDCl3)162.0,153.2,145.4,142.6(q,J(C-F)=35.1Hz),135.3,132.1,129.6,128.8,128.5,127.6,126.4,122.3,118.0(q,J(C-F)=277.4Hz),31.4.
19F NMR(377MHz,CDCl3)-64.0.
M.p.181-182℃
HRMS(ESI):[M+H]+calcd.for C19H18F3N2O 347.1366,found 347.1369.
nuclear magnetic resonance of 2-trifluoromethyl-substituted quinazolinone derivative (I-4) prepared in example 4: (1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0002672002320000081
1H NMR(400MHz,CDCl3)8.44-8.38(m,2H),8.31(d,J=7.9Hz,1H),7.92(d,J=3.7Hz,2H),7.73-7.64(m,1H),7.53(d,J=8.6Hz,2H).
13C NMR(101MHz,CDCl3)161.3,148.7,145.1,141.2(q,J(C-F)=36.0Hz),140.6,135.9,130.7,130.2,129.1,127.6,124.8,121.9,117.6(q,J(C-F)=277.5Hz).
19F NMR(377MHz,CDCl3)-63.8.
M.p.179-180℃
HRMS(ESI):[M+H]+calcd.for C15H9F3N3O3 336.0591,found 336.0593.
nuclear magnetic resonance of 2-trifluoromethyl-substituted quinazolinone derivative (I-5) prepared in example 5: (1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0002672002320000082
1H NMR(400MHz,CDCl3)8.38(d,J=9.0Hz,1H),8.05(d,J=8.3Hz,1H),7.98(t,J=7.6Hz,2H),7.93(t,J=7.0Hz,1H),7.69(t,J=6.9Hz,1H),7.65-7.59(m,1H),7.57-7.53(m,1H),7.53-7.48(m,2H),7.43(d,J=8.3Hz,1H).
13C NMR(101MHz,CDCl3)161.7,145.6,143.1(q,J(C-F)=36.0Hz),135.5,134.3,131.6,130.9,130.7,129.8,129.0,128.8,127.9,127.8,127.5,126.9,125.2,122.2,121.8,117.9(q,J(C-F)=277.6Hz).
19F NMR(377MHz,CDCl3)-64.8.
M.p.168-169℃
HRMS(ESI):[M+H]+calcd.for C19H12F3N2O 341.0896,found 341.0904.

Claims (9)

1. a preparation method of a 2-trifluoromethyl substituted quinazolinone derivative is characterized by comprising the following steps: adding a palladium catalyst, a ligand, a carbon monoxide substitute, an additive, trifluoroethylimidoyl chloride and o-iodoaniline into an organic solvent, reacting for 16-30 hours at 80-100 ℃, and after the reaction is completed, carrying out aftertreatment to obtain the 2-trifluoromethyl-substituted quinazolinone derivative;
the structure of the o-iodoaniline is shown as the formula (II):
Figure FDA0002672002310000011
the structure of the trifluoroethylimidoyl chloride is shown as a formula (III):
Figure FDA0002672002310000012
the structure of the 2-trifluoromethyl substituted quinazolinone derivative is shown as the formula (I):
Figure FDA0002672002310000013
in formulae (I) to (III), R1Is H, C1~C5Alkyl, halogen or trifluoromethyl;R2Is a substituted or unsubstituted aryl group;
the substituent on the aryl is selected from C1~C5Alkyl, alkoxy, halogen or nitro.
2. The method for preparing 2-trifluoromethyl-substituted quinazolinone derivatives according to claim 1, wherein R is1Is H, methyl, F, Cl, Br or-CF3
3. The method for preparing 2-trifluoromethyl-substituted quinazolinone derivatives according to claim 1, wherein R is2Is phenyl, 4-methylphenyl, 2-methylphenyl, 4-chlorophenyl, 4-nitrophenyl or 1-naphthyl.
4. The process for preparing a 2-trifluoromethyl-substituted quinazolinone derivative according to claim 1, characterized in that the molar ratio of o-iodoaniline: trifluoroethylimidoyl chloride: carbon monoxide substitute: palladium catalyst: ligand: the additive is 1: 1-3: 2-4: 0.01-0.1: 1-3.
5. The method for preparing a 2-trifluoromethyl-substituted quinazolinone derivative according to claim 1, wherein said organic solvent is tetrahydrofuran.
6. The method for preparing a 2-trifluoromethyl-substituted quinazolinone derivative according to claim 1, wherein said palladium catalyst is bis-triphenylphosphine palladium dichloride;
the ligand is 1, 3-bis (diphenylphosphino) propane.
7. The method for preparing a 2-trifluoromethyl-substituted quinazolinone derivative according to claim 1, wherein said additive is potassium tert-butoxide.
8. The method of claim 1, wherein the carbon monoxide substitute is phenol 1,3, 5-tricarboxylate.
9. The method for preparing a 2-trifluoromethyl-substituted quinazolinone derivative according to claim 1, wherein said 2-trifluoromethyl-substituted quinazolinone derivative is one of the derivatives represented by formula (I-1) to formula (I-5):
Figure FDA0002672002310000021
CN202010936182.9A 2020-09-08 2020-09-08 Preparation method of 2-trifluoromethyl substituted quinazolinone derivative Pending CN112125856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010936182.9A CN112125856A (en) 2020-09-08 2020-09-08 Preparation method of 2-trifluoromethyl substituted quinazolinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010936182.9A CN112125856A (en) 2020-09-08 2020-09-08 Preparation method of 2-trifluoromethyl substituted quinazolinone derivative

Publications (1)

Publication Number Publication Date
CN112125856A true CN112125856A (en) 2020-12-25

Family

ID=73845062

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010936182.9A Pending CN112125856A (en) 2020-09-08 2020-09-08 Preparation method of 2-trifluoromethyl substituted quinazolinone derivative

Country Status (1)

Country Link
CN (1) CN112125856A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113307790A (en) * 2021-05-24 2021-08-27 杭州职业技术学院 Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113773201A (en) * 2021-10-22 2021-12-10 天津医科大学 Trifluoromethyl-containing spiro [4,5] decane compound and preparation method thereof
CN114195711A (en) * 2021-12-20 2022-03-18 浙江理工大学 Preparation method of quinoline-4 (1H) -ketone compound
CN114478375A (en) * 2022-02-23 2022-05-13 浙江理工大学 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative
CN115403520A (en) * 2022-08-30 2022-11-29 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LE-CHENG WANG等: "FeCl3‑Mediated Synthesis of 2‑(Trifluoromethyl)quinazolin-4(3H)‑ones from Isatins and Trifluoroacetimidoyl Chlorides", 《ORG. LETT.》 *
ZHAOYAN ZHENG等: "Palladium-Catalyzed Cyclocarbonylation of o-Iodoanilines with Imidoyl Chlorides to Produce Quinazolin-4(3H)-ones", 《ORG. LETT.》 *
ZHENGKAI CHEN等: "Palladium-catalyzed three-component carbonylative synthesis of 2-(trifluoromethyl)quinazolin-4(3H)-ones from trifluoroacetimidoyl chlorides and amines", 《ORGANIC CHEMISTRY FRONTIERS》 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113307790A (en) * 2021-05-24 2021-08-27 杭州职业技术学院 Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113307790B (en) * 2021-05-24 2022-03-18 杭州职业技术学院 Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113773201A (en) * 2021-10-22 2021-12-10 天津医科大学 Trifluoromethyl-containing spiro [4,5] decane compound and preparation method thereof
CN113773201B (en) * 2021-10-22 2023-09-15 天津医科大学 Trifluoromethyl-containing spiro [4,5] decane compound and preparation method thereof
CN114195711A (en) * 2021-12-20 2022-03-18 浙江理工大学 Preparation method of quinoline-4 (1H) -ketone compound
CN114195711B (en) * 2021-12-20 2023-08-18 浙江理工大学 Preparation method of quinoline-4 (1H) -ketone compound
CN114478375A (en) * 2022-02-23 2022-05-13 浙江理工大学 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative
CN114478375B (en) * 2022-02-23 2023-08-18 浙江理工大学 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative
CN115403520A (en) * 2022-08-30 2022-11-29 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative
CN115403520B (en) * 2022-08-30 2023-12-19 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative

Similar Documents

Publication Publication Date Title
CN112125856A (en) Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
CN111675662B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound
CN111978265B (en) Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole derivative
CN111423381B (en) Preparation method of 2-trifluoromethyl substituted imidazole compound
CN113105402B (en) Preparation method of 3,4, 5-trisubstituted 1,2, 4-triazole compound
CN110467579B (en) Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113307790B (en) Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113121462B (en) Preparation method of 5-trifluoromethyl substituted 1,2,3-triazole compound
CN113045489A (en) Preparation method of 3-arylquinoline-2 (1H) ketone derivative
CN113307778A (en) Preparation method of 3-trifluoromethyl substituted 1,2, 4-triazole compound
CN112480015B (en) Method for synthesizing 2-trifluoromethyl substituted quinazolinone by multi-component one-pot method
CN113045503B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound and application of compound in synthesis of drug molecules
CN113735778B (en) Preparation method of 5-trifluoromethyl substituted imidazole compound
CN113880781B (en) Method for synthesizing 3-trifluoromethyl substituted 1,2, 4-triazole compound by taking glucose as carbon source
CN111978194A (en) Preparation method of aryl acetamide compound
CN112239456B (en) Preparation method of substituted 2, 3-dihydroquinolone compound
CN113683595B (en) Preparation method of simple sulfur-promoted 5-trifluoromethyl-substituted 1,2, 4-triazole compound
CN114195726B (en) Preparation method of 1,2, 4-triazole substituted arylamine compound
CN112538054B (en) Preparation method of 1,2, 4-triazole-3-ketone compound
CN115246786B (en) Preparation method of indole compound or benzoxazine compound
CN115286609B (en) Preparation method of 2-trifluoromethyl substituted dihydrobenzochromene
CN115385895A (en) Preparation method of 2-trifluoromethyl substituted indole compound
CN115353511A (en) Method for synthesizing carbonyl bridged bis-heterocyclic compound from multiple components
CN113072510A (en) Green preparation method of 1,2, 4-triazole-3-ketone compound
CN109535076B (en) Preparation method of 2, 3-dihydroquinoline-4-ketone compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination